Oncology drug health technology assessment recommendations: Canadian versus UK experiences.
about
Use of Intermediate Endpoints in the Economic Evaluation of New Treatments for Advanced Cancer and Methods Adopted When Suitable Overall Survival Data are Not Available.Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in bulgaria.Principles for consistent value assessment and sustainable funding of orphan drugs in Europe.A Time-Trend Economic Analysis of Cancer Drug Trials.A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in BulgariaRelative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries.Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR).Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.NICE, social values, and balancing objectivity and equity.
P2860
Q31061574-A9FD467C-70F5-4BD0-A015-CEE7AD1271C0Q35522232-D6C6ABFE-5040-4334-9498-50205E247322Q35610429-A93C8282-B22B-4B77-825C-4372072C5108Q35820527-3B5C8E14-7CC3-47A8-A989-C38BCEBE8659Q35901707-46E26E0C-4D1B-490D-916F-ACE38194F726Q36618422-0211057A-A04C-4BC4-B754-91EE0D3F0E63Q39666107-05CA3A03-8AEC-45EF-9F0D-D4B733C9CC82Q47123934-B4ED0C2C-7895-4C65-8D6E-AEADC3AD5527Q50238133-654C2F87-C819-48A4-9038-66D0C74C4FACQ51787832-141DAD96-EAE9-4B4B-813D-768C42C10A5D
P2860
Oncology drug health technology assessment recommendations: Canadian versus UK experiences.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Oncology drug health technolog ...... anadian versus UK experiences.
@ast
Oncology drug health technolog ...... anadian versus UK experiences.
@en
type
label
Oncology drug health technolog ...... anadian versus UK experiences.
@ast
Oncology drug health technolog ...... anadian versus UK experiences.
@en
prefLabel
Oncology drug health technolog ...... anadian versus UK experiences.
@ast
Oncology drug health technolog ...... anadian versus UK experiences.
@en
P2860
P356
P1476
Oncology drug health technolog ...... anadian versus UK experiences.
@en
P2093
Angela Rocchi
Isabelle Chabot
P2860
P304
P356
10.2147/CEOR.S66309
P407
P577
2014-07-16T00:00:00Z